Cargando…
AAV9-based gene therapy partially ameliorates the clinical phenotype of a mouse model of Leigh syndrome
Leigh syndrome (LS) is the most common infantile mitochondrial encephalopathy. No treatment is currently available for this condition. Mice lacking Ndufs4, encoding NADH: ubiquinone oxidoreductase iron-sulfur protein 4 (NDUFS4) recapitulates the main findings of complex I (cI)-related LS, including...
Autores principales: | Di Meo, I, Marchet, S, Lamperti, C, Zeviani, M, Viscomi, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658670/ https://www.ncbi.nlm.nih.gov/pubmed/28753212 http://dx.doi.org/10.1038/gt.2017.53 |
Ejemplares similares
-
Effective AAV-mediated gene therapy in a mouse model of ethylmalonic encephalopathy
por: Di Meo, Ivano, et al.
Publicado: (2012) -
Double administration of self-complementary AAV9(NDUFS4) prevents Leigh disease in Ndufs4(−/−) mice
por: Corrà, Samantha, et al.
Publicado: (2022) -
Opa1 Overexpression Ameliorates the Phenotype of Two Mitochondrial Disease Mouse Models
por: Civiletto, Gabriele, et al.
Publicado: (2015) -
NAD(+)-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial Disease
por: Cerutti, Raffaele, et al.
Publicado: (2014) -
A Single Intravenous Injection of AAV-PHP.B-hNDUFS4 Ameliorates the Phenotype of Ndufs4(−/−) Mice
por: Silva-Pinheiro, Pedro, et al.
Publicado: (2020)